← Back
$NRIX All transactions

Nurix Therapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$124K

Shares

8,148

Price

$15

Filed

Apr 2

Insider

Name

Ring Christine

Title

Chief Legal Officer

CIK

0001817199

Roles

Officer

Transaction Details

Transaction Date

2026-04-02

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

26,453

Footnotes

This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. | Represents the weighted average sale price. The lowest price at which shares were sold was $15.00 and the highest price at which shares were sold was $15.43. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.

Filing Info

Accession No.

0001817199-26-000012

Form Type

4

Issuer CIK

0001549595

Ring Christine's History

Date Ticker Type Value
2026-04-02 NRIX $124K
2026-03-02 NRIX $126K
2026-02-10 NRIX A $0
2026-02-10 NRIX A $0
2026-02-09 NRIX $238K
2026-01-30 NRIX M $0
2026-01-30 NRIX M $0
2026-01-30 NRIX M $0
2026-01-30 NRIX M $0
2026-01-30 NRIX $72K

Other Insiders at NRIX (90d)

Insider Bought Sold Last
SANDS ARTHUR T
President, CEO
2026-02-10
Hansen Gwenn
Chief Scientific Officer
$81K 2026-02-10
Ring Christine
Chief Legal Officer
$437K 2026-03-02
van Houte Hans
Chief Financial Officer
$61K 2026-02-10